{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:53:52Z","timestamp":1791237232639,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274260"],"award-info":[{"award-number":["82274260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrep.2026.102753","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:15:08Z","timestamp":1787771708000},"page":"102753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanism of FXR signaling: from liver inflammation to hepatocellular carcinoma"],"prefix":"10.1016","volume":"47","author":[{"given":"Cheng","family":"Qiuluo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Guiqun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbrep.2026.102753_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.bbrep.2026.102753_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102753_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6","key":"10.1016\/j.bbrep.2026.102753_bib4","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bbrep.2026.102753_bib5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.gendis.2023.03.010","article-title":"Genetic landscape and clinical significance of cuproptosis-related genes in liver hepatocellular carcinoma","volume":"11","author":"Hu","year":"2024","journal-title":"Genes Dis."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102753_bib6","first-page":"17","article-title":"Diagnostic and treatment guidelines for primary liver cancer (2024 edition)","volume":"10","year":"2024","journal-title":"J. Multidis. Cancer Manag. (Electronic Version)"},{"issue":"5","key":"10.1016\/j.bbrep.2026.102753_bib7","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41401-021-00849-4","article-title":"FXR: structures, biology, and drug development for NASH and fibrosis diseases","volume":"43","author":"Tian","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102753_bib8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bcp.2013.07.022","article-title":"Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition","volume":"86","author":"Vaquero","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102753_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/aps.2014.117","article-title":"FXR and liver carcinogenesis","volume":"36","author":"Huang","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102753_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/nu13041104","article-title":"Role of bile acids in the regulation of food intake, and their dysregulation in metabolic disease","volume":"13","author":"Xie","year":"2021","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.bbrep.2026.102753_bib11","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3350\/cmh.2023.0110","article-title":"Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: a nationwide study","volume":"29","author":"Lee","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"issue":"Suppl 2","key":"10.1016\/j.bbrep.2026.102753_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000440705","article-title":"Worldwide incidence of autoimmune liver disease","volume":"33","author":"Jepsen","year":"2015","journal-title":"Dig. Dis."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102753_bib13","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.bbrep.2026.102753_bib14","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"19","key":"10.1016\/j.bbrep.2026.102753_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/foods13193076","article-title":"Isorhamnetin in quinoa whole-grain flavonoids intervenes in non-alcoholic fatty liver disease by modulating bile acid metabolism through regulation of FXR expression","volume":"13","author":"La","year":"2024","journal-title":"Foods"},{"issue":"4","key":"10.1016\/j.bbrep.2026.102753_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102753_bib17","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.bbrep.2026.102753_bib18","doi-asserted-by":"crossref","first-page":"G893","DOI":"10.1152\/ajpgi.00337.2013","article-title":"Fibroblast growth factor 15 deficiency impairs liver regeneration in mice","volume":"306","author":"Kong","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102753_bib19","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1038\/s41467-020-19803-9","article-title":"Intestinal FGF15\/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102753_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1142\/S0192415X25500120","article-title":"Ameliorative effect of glycyrrhizic acid on diosbulbin B-Induced liver injury and its mechanism","volume":"53","author":"Wang","year":"2025","journal-title":"Am. J. Chin. Med."},{"issue":"11","key":"10.1016\/j.bbrep.2026.102753_bib21","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/jat.4667","article-title":"Oleanolic acid induces hepatic injury by disrupting hepatocyte tight junction and dysregulation of farnesoid X receptor-mediated bile acid efflux transporters","volume":"44","author":"Zeng","year":"2024","journal-title":"J. Appl. Toxicol."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102753_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166930","article-title":"Farnesoid X receptor overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in nonalcoholic fatty liver disease","volume":"1870","author":"Xu","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102753_bib23","first-page":"70","article-title":"Didymin attenuates doxorubicin-induced cardiotoxicity by inhibiting oxidative stress","volume":"14","author":"Chen","year":"2022","journal-title":"Chin Herb Med"},{"issue":"12","key":"10.1016\/j.bbrep.2026.102753_bib24","first-page":"1961","article-title":"Restraint stress promotes nonalcoholic steatohepatitis by regulating the farnesoid X receptor\/NLRP3 signaling pathway","volume":"55","author":"Yang","year":"2023","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102753_bib25","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/j.gastro.2015.02.056","article-title":"\u03b2-Catenin signaling and roles in liver homeostasis, injury, and tumorigenesis","volume":"148","author":"Monga","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bbrep.2026.102753_bib26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/hep.29371","article-title":"\u03b2-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis","volume":"67","author":"Thompson","year":"2018","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.bbrep.2026.102753_bib27","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/hep4.1430","article-title":"Activation of WNT\/Beta-Catenin signaling and regulation of the Farnesoid X Receptor\/Beta-Catenin complex after Murine bile duct ligation","volume":"3","author":"Zhang","year":"2019","journal-title":"Hepatol. Commun."},{"issue":"6","key":"10.1016\/j.bbrep.2026.102753_bib28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jcmgh.2023.08.004","article-title":"Inhibiting wnt signaling reduces cholestatic injury by disrupting the inflammatory axis","volume":"16","author":"Ayers","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrep.2026.102753_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117038","article-title":"Pirfenidone ameliorates ANIT-induced cholestatic liver injury via modulation of FXR, NF-\u043aB\/TNF-\u03b1, and Wnt\/GSK-3\u03b2\/\u03b2-catenin signaling pathways","volume":"490","author":"Abdulaal","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102753_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118282","article-title":"Protective effects and mechanism of Sangyu granule on acetaminophen-induced liver injury in mice","volume":"331","author":"Xiao","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"Pt 4","key":"10.1016\/j.bbrep.2026.102753_bib31","article-title":"Salidroside attenuates NASH through regulating bile acid-FXR\/TGR5 signaling pathway via targeting gut microbiota","volume":"307","author":"Zhang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"13","key":"10.1016\/j.bbrep.2026.102753_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/foods12132492","article-title":"Ginsenoside Rh4 improves hepatic lipid metabolism and inflammation in a model of NAFLD by targeting the gut liver axis and modulating the FXR signaling pathway","volume":"12","author":"Yang","year":"2023","journal-title":"Foods"},{"issue":"19","key":"10.1016\/j.bbrep.2026.102753_bib33","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1111\/bph.16431","article-title":"A commonly used therapeutic agent for non-alcohol fatty liver disease, functions through upregulating intestinal expression of fibroblast growth factor 15\/19","volume":"181","author":"Bai","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102753_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.164307","article-title":"Bisphenol A induced hepatic steatosis by disturbing bile acid metabolism and FXR\/TGR5 signaling pathways via remodeling the gut microbiota in CD-1 mice","volume":"889","author":"Hong","year":"2023","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.bbrep.2026.102753_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156460","article-title":"Multiomics combined analysis reveals protective effect of 7-O-\u03b1-L-rhamnopyranosyl-kaempferol-3-O-\u03b2-D-glucopyranoside on autoimmune hepatitis","volume":"139","author":"Xiao","year":"2025","journal-title":"Phytomedicine"},{"issue":"22","key":"10.1016\/j.bbrep.2026.102753_bib36","doi-asserted-by":"crossref","first-page":"12097","DOI":"10.1073\/pnas.200367697","article-title":"Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha","volume":"97","author":"Venkateswaran","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102753_bib37","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1039\/D4FO03731F","article-title":"Brassica oleracea L. var. italica Planch) alleviates metabolic-associated fatty liver disease through regulating gut flora and lipid metabolism via the FXR\/LXR signaling pathway","volume":"16","author":"Lu","year":"2025","journal-title":"Food Funct."},{"key":"10.1016\/j.bbrep.2026.102753_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1135952","article-title":"The ameliorating effect of withaferin A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR\/FXR dual receptor activator","volume":"14","author":"Shiragannavar","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102753_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/hmg\/9.2.289","article-title":"A novel human odorant-binding protein gene family resulting from genomic duplicons at 9q34: differential expression in the oral and genital spheres","volume":"9","author":"Lacazette","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102753_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/brv.12787","article-title":"Odorant-binding proteins of mammals","volume":"97","author":"Pelosi","year":"2022","journal-title":"Biol. Rev. Camb. Phil. Soc."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102753_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40246-019-0191-9","article-title":"Update on the human and mouse lipocalin (LCN) gene family, including evidence the mouse Mup cluster is result of an \"evolutionary bloom\"","volume":"13","author":"Charkoftaki","year":"2019","journal-title":"Hum Genomics"},{"issue":"3","key":"10.1016\/j.bbrep.2026.102753_bib42","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/MCB.00459-10","article-title":"Lipocalin-13 regulates glucose metabolism by both insulin-dependent and insulin-independent mechanisms","volume":"31","author":"Cho","year":"2011","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrep.2026.102753_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111812","article-title":"Elevated expression of LCN13 through FXR activation ameliorates hepatocellular lipid accumulation and inflammation","volume":"131","author":"Qin","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"17","key":"10.1016\/j.bbrep.2026.102753_bib44","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective Study of outcomes in adults with nonalcoholic Fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102753_bib45","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","article-title":"The power of plasticity-metabolic regulation of hepatic stellate cells","volume":"33","author":"Trivedi","year":"2021","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102753_bib46","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","article-title":"Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis","volume":"75","author":"Xiong","year":"2019","journal-title":"Mol Cell"},{"issue":"3","key":"10.1016\/j.bbrep.2026.102753_bib47","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrep.2026.102753_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.addr.2017.07.014","article-title":"The good and the bad collagens of fibrosis - their role in signaling and organ function","volume":"121","author":"Karsdal","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.bbrep.2026.102753_bib49","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.bbrep.2026.102753_bib50","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000574","article-title":"Aberrant basement membrane production by HSCs in MASLD is attenuated by the bile acid analog INT-767","volume":"8","author":"Ramachandran","year":"2024","journal-title":"Hepatol. Commun."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102753_bib51","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11418-024-01780-8","article-title":"Angelica dahurica extract and its effective component bergapten alleviated hepatic fibrosis by activating FXR signaling pathway","volume":"78","author":"Gao","year":"2024","journal-title":"J. Nat. Med."},{"issue":"28","key":"10.1016\/j.bbrep.2026.102753_bib52","doi-asserted-by":"crossref","first-page":"15740","DOI":"10.1021\/acs.jafc.4c03286","article-title":"Raspberry ketone attenuates hepatic fibrogenesis and inflammation via regulating the crosstalk of FXR and PGC-1\u03b1 signaling","volume":"72","author":"Jiang","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbrep.2026.102753_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.128867","article-title":"NLRP3 inflammasome-mediated endothelial cells pyroptosis is involved in decabromodiphenyl ethane-induced vascular endothelial injury","volume":"267","author":"Zheng","year":"2021","journal-title":"Chemosphere"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102753_bib54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41392-023-01727-7","article-title":"Hepatic Zbtb18 (Zinc Finger and BTB domain containing 18) alleviates hepatic steatohepatitis via FXR (Farnesoid X Receptor)","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102753_bib55","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s12072-023-10610-0","article-title":"Bile acids induce liver fibrosis through the NLRP3 inflammasome pathway and the mechanism of FXR inhibition of NLRP3 activation","volume":"18","author":"Feng","year":"2024","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.bbrep.2026.102753_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115965","article-title":"Sini San ameliorates CCl4-induced liver fibrosis in mice by inhibiting AKT-mediated hepatocyte apoptosis","volume":"303","author":"Jiang","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"8","key":"10.1016\/j.bbrep.2026.102753_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.70005","article-title":"Melatonin ameliorates cadmium-induced liver fibrosis via modulating Gut Microbiota and bile acid metabolism","volume":"76","author":"Liu","year":"2024","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.bbrep.2026.102753_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111364","article-title":"Obeticholic acid aggravates liver fibrosis by activating hepatic farnesoid X receptor-induced apoptosis in cholestatic mice","volume":"406","author":"Lu","year":"2025","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.bbrep.2026.102753_bib59","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jcmgh.2023.08.003","article-title":"GLP-2 improves hepatic inflammation and fibrosis in Mdr2(-\/-) mice via activation of NR4a1\/Nur77 in hepatic stellate cells and intestinal FXR signaling","volume":"16","author":"Fuchs","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102753_bib60","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s12072-023-10636-4","article-title":"FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence","volume":"18","author":"Simbrunner","year":"2024","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.bbrep.2026.102753_bib61","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.91438.3","article-title":"Hammerhead-type FXR agonists induce an enhancer RNA Fincor that ameliorates nonalcoholic steatohepatitis in mice","volume":"13","author":"Chen","year":"2024","journal-title":"eLife"},{"issue":"20","key":"10.1016\/j.bbrep.2026.102753_bib62","doi-asserted-by":"crossref","first-page":"18334","DOI":"10.1021\/acs.jmedchem.4c01651","article-title":"Design, synthesis, and pharmacological evaluation of dual FXR-LIFR modulators for the treatment of liver fibrosis","volume":"67","author":"Rapacciuolo","year":"2024","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bbrep.2026.102753_bib63","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/j.gastro.2016.08.057","article-title":"An intestinal Microbiota-Farnesoid X receptor axis modulates Metabolic disease","volume":"151","author":"Gonzalez","year":"2016","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bbrep.2026.102753_bib64","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.bbrep.2026.102753_bib65","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/cr.2008.289","article-title":"FXR: a metabolic regulator and cell protector","volume":"18","author":"Wang","year":"2008","journal-title":"Cell Res."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102753_bib66","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1158\/0008-5472.CAN-06-1078","article-title":"Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.bbrep.2026.102753_bib67","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.2174\/0113816128342642250111055339","article-title":"Crippled hepatocarcinogenesis inhibition of Quercetin in glycolysis pathway with hepatic farnesoid X receptor deficiency","volume":"31","author":"Zhong","year":"2025","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.bbrep.2026.102753_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065174","article-title":"C-Terminal truncated HBx facilitates oncogenesis by modulating cell cycle and glucose metabolism in FXR-deficient hepatocellular carcinoma","volume":"24","author":"Wu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2026.102753_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198264","article-title":"Partial abrogation of FXR-KNG1 signaling by carboxyl-terminal truncated HBx-C30 in hepatitis B virus-associated hepatocellular carcinoma","volume":"293","author":"Niu","year":"2021","journal-title":"Virus Res."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102753_bib70","article-title":"TDG is a novel tumor suppressor of liver malignancies","volume":"7","author":"Hassan","year":"2020","journal-title":"Mol Cell Oncol"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102753_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.03.039","article-title":"Loss of thymine DNA glycosylase causes dysregulation of bile acid homeostasis and hepatocellular carcinoma","volume":"31","author":"Hassan","year":"2020","journal-title":"Cell Rep."},{"issue":"24","key":"10.1016\/j.bbrep.2026.102753_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246191","article-title":"Regulation of chromatin accessibility by the farnesoid X receptor is essential for circadian and bile acid homeostasis in vivo","volume":"14","author":"Hassan","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.bbrep.2026.102753_bib73","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/path.5780","article-title":"Disordered farnesoid X receptor signaling is associated with liver carcinogenesis in Abcb11-deficient mice","volume":"255","author":"Wang","year":"2021","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102753_bib74","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.devcel.2018.12.021","article-title":"FGF15 activates hippo signaling to suppress bile acid metabolism and liver tumorigenesis","volume":"48","author":"Ji","year":"2019","journal-title":"Dev. Cell"},{"issue":"4","key":"10.1016\/j.bbrep.2026.102753_bib75","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102753_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010217","article-title":"Role of JAK\/STAT3 signaling in the regulation of metastasis, the transition of cancer stem cells, and chemoresistance of cancer by epithelial-mesenchymal transition","volume":"9","author":"Jin","year":"2020","journal-title":"Cells"},{"issue":"24","key":"10.1016\/j.bbrep.2026.102753_bib77","doi-asserted-by":"crossref","first-page":"14549","DOI":"10.1111\/jcmm.16083","article-title":"Farnesoid X receptor activation induces antitumour activity in colorectal cancer by suppressing JAK2\/STAT3 signalling via transactivation of SOCS3 gene","volume":"24","author":"Li","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102753_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26031122","article-title":"Farnesoid X receptor attenuates the tumorigenicity of liver cancer stem cells by inhibiting STAT3 phosphorylation","volume":"26","author":"Ye","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbrep.2026.102753_bib79","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.18632\/aging.203920","article-title":"P53\/miR-34a\/SIRT1 positive feedback loop regulates the termination of liver regeneration","volume":"15","author":"Gong","year":"2023","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102753_bib80","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3892\/ol.2022.13608","article-title":"FXR1 promotes proliferation, invasion and migration of hepatocellular carcinoma in vitro and in vivo","volume":"25","author":"Zhao","year":"2023","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102753_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071898","article-title":"Farnesoid X receptor activation enhances transforming growth factor \u03b2-Induced epithelial-mesenchymal transition in hepatocellular carcinoma cells","volume":"19","author":"Kainuma","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102753_bib82","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1053\/gast.2001.24798","article-title":"Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis","volume":"120","author":"Laurent-Puig","year":"2001","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102753_bib83","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12986-022-00693-1","article-title":"Alpha-linolenic acid inhibits hepatocellular carcinoma cell growth through farnesoid X receptor\/\u03b2-catenin signaling pathway","volume":"19","author":"Feng","year":"2022","journal-title":"Nutr. Metab."},{"issue":"21","key":"10.1016\/j.bbrep.2026.102753_bib84","article-title":"CRISPR\/Cas9 screens reveal that hexokinase 2 enhances cancer stemness and tumorigenicity by activating the ACSL4-Fatty acid \u03b2-Oxidation pathway","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"6","key":"10.1016\/j.bbrep.2026.102753_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/biology12060864","article-title":"The ACSL4 network regulates cell death and autophagy in diseases","volume":"12","author":"Chen","year":"2023","journal-title":"Biology"},{"issue":"9","key":"10.1016\/j.bbrep.2026.102753_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.706","article-title":"Role of ACSL4 in modulating farnesoid X receptor expression and M2 macrophage polarization in HBV-induced hepatocellular carcinoma","volume":"5","author":"Chen","year":"2024","journal-title":"MedComm"},{"issue":"5","key":"10.1016\/j.bbrep.2026.102753_bib87","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10585-015-9718-1","article-title":"Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation","volume":"32","author":"Ricciardelli","year":"2015","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bbrep.2026.102753_bib88","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2162-3619-2-18","article-title":"Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells","volume":"2","author":"Wang","year":"2013","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102753_bib89","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41419-020-2225-6","article-title":"The nuclear translocation of transketolase inhibits the farnesoid receptor expression by promoting the binding of HDAC3 to FXR promoter in hepatocellular carcinoma cell lines","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.bbrep.2026.102753_bib90","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41416-025-03089-z","article-title":"New mechanistic understanding of FXR agonist Vonafexor: inducing sublethal damage of HBV-positive liver cancer cells via promoting anti-tumor immunity","volume":"133","author":"Pan","year":"2025","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrep.2026.102753_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.711448","article-title":"Norcholic acid promotes tumor progression and immune escape by regulating farnesoid X receptor in hepatocellular carcinoma","volume":"11","author":"Gong","year":"2021","journal-title":"Front. Oncol."},{"issue":"43","key":"10.1016\/j.bbrep.2026.102753_bib92","doi-asserted-by":"crossref","first-page":"E10127","DOI":"10.1073\/pnas.1722100115","article-title":"iNOS promotes CD24(+)CD133(+) liver cancer stem cell phenotype through a TACE\/ADAM17-dependent notch signaling pathway","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102753_bib93","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.stem.2016.01.006","article-title":"A miR-34a-Numb feedforward loop triggered by inflammation regulates Asymmetric stem cell division in intestine and Colon cancer","volume":"18","author":"Bu","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102753_bib94","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13287-021-02298-6","article-title":"Farnesoid X receptor via Notch1 directs asymmetric cell division of Sox9(+) cells to prevent the development of liver cancer in a mouse model","volume":"12","author":"Chen","year":"2021","journal-title":"Stem Cell Res. Ther."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102753_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071971","article-title":"JAK-STAT signalling pathway in cancer","volume":"12","author":"Brooks","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrep.2026.102753_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114497","article-title":"Activation of FXR modulates SOCS3\/Jak2\/STAT3 signaling axis in a NASH-dependent hepatocellular carcinoma animal model","volume":"186","author":"Attia","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102753_bib97","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40364-024-00694-7","article-title":"Noninvasive biomarkers implicated in urea and TCA cycles for metabolic liver disease","volume":"12","author":"Yang","year":"2024","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102753_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.108022","article-title":"Alternative splicing is an FXR\u03b1 loss-of-function mechanism and impacts energy metabolism in hepatocarcinoma cells","volume":"301","author":"Garcia","year":"2025","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bbrep.2026.102753_bib99","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.31557\/APJCP.2023.24.9.3221","article-title":"Interpretation of Farnesoid X receptor immunohistochemical expression in discriminating hepatocellular carcinoma from its non-neoplastic mimics as an adjunct to glypican 3","volume":"24","author":"Salama","year":"2023","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.bbrep.2026.102753_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1124240","article-title":"Celastrol-regulated gut microbiota and bile acid metabolism alleviate hepatocellular carcinoma proliferation by regulating the interaction between FXR and RXR\u03b1 in vivo and in vitro","volume":"14","author":"Zeng","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbrep.2026.102753_bib101","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200171R","article-title":"Dihydroartemisinin promoted FXR expression independent of YAP1 in hepatocellular carcinoma","volume":"36","author":"Guo","year":"2022","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102753_bib102","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0092-8674(01)00616-X","article-title":"microRNAs: tiny regulators with great potential","volume":"107","author":"Ambros","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bbrep.2026.102753_bib103","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3389\/fphar.2018.00657","article-title":"Interplay of miRNAs and canonical wnt signaling pathway in hepatocellular carcinoma","volume":"9","author":"Nie","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102753_bib104","doi-asserted-by":"crossref","first-page":"771","DOI":"10.7150\/jca.49680","article-title":"Upregulation of miR-1254 promotes Hepatocellular carcinoma cell Proliferation, Migration, and Invasion via Inactivation of the Hippo-YAP signaling pathway by decreasing PAX5","volume":"12","author":"Lu","year":"2021","journal-title":"J. Cancer"}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826003134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826003134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:01:44Z","timestamp":1791234104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580826003134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":104,"alternative-id":["S2405580826003134"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102753","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of FXR signaling: from liver inflammation to hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102753"}}